Project

General

Profile

Obj. 1: Testing/identify PLHIV #490

Obj. 1: Testing/identify PLHIV #339: 1.10: Provide prevention services to KPs, including PrEP

Implement PrEP in selected facilities

Added by Gilles about 1 year ago. Updated about 1 year ago.

Status:
New
Priority:
Normal
Assignee:
-
Start date:
04/01/2023
Due date:
09/30/2023 (about 12 months late)
% Done:

0%

Estimated time:
(Total: 0.00 h)
Spent time:
(Total: 2.00 h)
Additional Details
Rate $ Hourly
Additional Assignee

Subtasks

Obj. 1: Testing/identify PLHIV #494: Train APS Testers at facility entry points by cluster on KP risk assessment for the identification and classification of walk-in KPs at facility entry points and KP in the community.New04/01/202306/30/2023

Actions
Obj. 1: Testing/identify PLHIV #495: Train HCW of selected facilities(11) on PrEP implementationNew04/01/202306/30/2023

Actions
Obj. 1: Testing/identify PLHIV #496: Provide regular mentorship of HCW of selected facilities on PrEP implementationNew04/01/202308/31/2023

Actions
Obj. 1: Testing/identify PLHIV #497: Provide regular mentorship of HCW of selected facilities on PrEP implementationNew04/01/202309/30/2023

Actions
Obj. 1: Testing/identify PLHIV #498: Engage KP peer leaders/peer navigators and expert KPs in the sensitisation on PrEP services for demande creation.New04/01/202309/30/2023

Actions
Obj. 1: Testing/identify PLHIV #499: Create a referral network for PrEP implementation such that the selected tier 1 and tier 2 PrEP facilities will serve as a hub for PrEP enrolment of eligible FSW and MSM tested negative in the spoke sites within the district. New04/01/202309/30/2023

Actions
Obj. 1: Testing/identify PLHIV #500: Linelist and retest all FSW and MSM who were previously tested negative for enrolment on PrEP.New04/01/202309/30/2023

Actions
Obj. 1: Testing/identify PLHIV #501: Print Standard Registers, Clients' Files, and sensitisation material like fyers, posters etc for PrEP implementation.New04/01/202309/30/2023

Actions
Obj. 1: Testing/identify PLHIV #502: Clinical monitoring and pharmaco-vigilance of PrEP clients at every visit( signs of acute HIV infection, side effects, creatinin clearance rate, hiv testing during each visit to ensure client is negative)New04/01/202309/30/2023

Actions

No data to display

Also available in: Atom PDF